PTEN and neoplasm: Interestingly, Pten‐null cancers seem resistant to immune checkpoint inhibitory antibodies, where PTEN loss in tumor cells increases the expression of immunosuppressive cytokines inhibiting trafficking and T cell‐mediated killing of tumors [57, 58].